Guizhou Bailin: Compound One Yellow Flower Spray Approved to Expand for Children's Use.

Guizhou Bailin announced that the company has received the approval notice of supplementary application for drug approval issued by the National Medical Products Administration, approving the expansion of the main treatment population of Compound Yellow Flower Spray for Acute Pharyngitis to "children aged 6-13", and at the same time completing the upgrade of drug specification formulation. This approved supplementary application mainly focuses on two directions: firstly, expanding the population suitable for acute pharyngitis to "children aged 6-13", increasing the accurate medication needs of children of this age group with acute pharyngitis; secondly, standardizing the specification formulation by adding "", further standardizing product specifications to meet current regulatory requirements. The product is still managed as a Class A non-prescription drug, with the package insert and label being updated synchronously, providing a scientific basis for clinical promotion and home use.